Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,243.00
Bid: 1,244.80
Ask: 1,245.80
Change: 18.80 (1.54%)
Spread: 1.00 (0.08%)
Open: 1,212.40
High: 1,247.00
Low: 1,210.80
Yest. Close: 1,224.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Monday broker round-up

(Sharecast News) - Hammerson: Peel Hunt upgrades to add with a target price of 350p.

17 Jun 19 12:21

GSK to update on potential cancer treatment at European congress

(Sharecast News) - GlaxoSmithKline is to present studies on a potential breakthrough cancer treatment at a major conference, the drugs giant confirmed on Wednesday.

12 Jun 19 12:34

LONDON MARKET PRE-OPEN: Smiths Finds Medical CEO; Ferrexpo Improves

LONDON (Alliance News) - Stock prices in London are set to open higher Friday after a disappointing finish Thursday as the European Central Bank failed to boost sentiment.In London, FTSE Smiths a

7 Jun 19 07:36

US approves self administration for GlaxoSmithKline asthma drug

(Sharecast News) - GlaxoSmithKline said on Friday that US regulators had approved two new methods for self-administering its Nucala asthma treatment.

7 Jun 19 07:15

May And Trump To Co-Host Meeting With UK And US Business Leaders

LONDON (Alliance News) - Prime Minister Theresa May and US President Donald Trump will co-host a meeting of British and American business leaders in a bid to boost trade.The prime minister

4 Jun 19 07:28

Fitch Cuts Glaxo Default Rating To A- From A After Acquisitions

LONDON (Alliance News) - Fitch Ratings on Tuesday downgraded GlaxoSmithKline PLC's long-term issuer default rating to A- from A as it expects Glaxo's leverage to remain high after recent a

29 May 19 10:37

GlaxoSmithKline's Shingrix Shingles Vaccine Gets Chinese Approval

LONDON (Alliance News) - GlaxoSmithKline PLC on Thursday said its Shingrix vaccine has been approved in China for the prevention of shingles in adults over 50 years old.Shingles is caused a

23 May 19 17:14

Thermo Fisher To Buy Irish Glaxo Manufacturing Site For EUR90 Million

LONDON (Alliance News) - Thermo Fisher Scientific Inc on Thursday announced a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline PLC for in

16 May 19 11:26

WINNERS & LOSERS SUMMARY: Domino's Pizza Warns Of International Loss

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 1.8%. The telecommunications firm said it

7 May 19 10:44

Glaxo Says Phase Three Study Of Trelegy Ellipta Meets Primary Endpoint

LONDON (Alliance News) - GlaxoSmithKline PLC and its partner Innoviva Inc on Thursday said the phase three Captain study of once-daily single inhaler triple therapy Trelegy Ellipta met its primary

2 May 19 17:24

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 2 MayOld MutualMpac GroupHowden Joinery GroupReachKAZ 3 6

1 May 19 16:20

TOP NEWS: Vaccine Sales Jump-Start GlaxoSmithKline First Quarter

LONDON (Alliance News) - GlaxoSmithKline PLC on Wednesday reported a rise in profit for the first quarter of the year, led by a continuing rise in vaccine sales.The pharmaceutical firm of

1 May 19 12:36

GlaxoSmithKline Q1 revenues boosted by shingles vaccine

(Sharecast News) - GlaxoSmithKline posted a rise in first-quarter sales on Wednesday as its vaccines division benefited from strong US sales of shingles vaccine Shingrix.

1 May 19 12:31

Venture Life Hires Former Glaxo Executive To Lead Finance Department

LONDON (Alliance News) - Self-care products firm Venture Life Group PLC on Wednesday announced the appointment of former GlaxoSmithKline PLC executive Andrew Waters as chief financial who joins of

1 May 19 10:39

Glaxo's ViiV Healthcare Submits New Drug Application For HIV Treatment

LONDON (Alliance News) - GlaxoSmithKline PLC on Monday said ViiV Healthcare is seeking US Food & Drug Administration approval for the investigational, monthly, injectable, two-drug regimen of

29 Apr 19 12:24

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.